Capital Health Partners Acquires Calea (Canada) from Fresenius Kabi, Creating Canada’s Largest Home Infusion and TPN Provider

Capital Health Partners Inc. is pleased to announce the successful acquisition of Calea from Fresenius Kabi. This transaction marks a significant milestone in Capital Health Partners’ mission to transform and expand home-based healthcare across Canada.

With the addition of Calea to its group of companies—which includes Ontario Medical Supply (OMS) and Royal Drugs—Capital Health Partners will become Canada’s largest and most comprehensive provider of home infusion and TPN care.

There will be no immediate changes to daily operations. Teams from OMS, Royal Drugs, and Calea are working closely to ensure a smooth and thoughtful integration process. Throughout the transition, open communication, transparency, patient care, and employee support will remain top priorities.